Press releases
- PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
- PacBio Announces First Quarter 2024 Financial Results
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
- Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
- PacBio Grants Equity Incentive Award to New Employee
More ▼
Key statistics
As of last trade, Pacific Biosciences of California Inc (P09:FRA) traded at 1.66, 40.65% above the 52 week low of 1.18 set on Apr 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.66 |
---|---|
High | 1.66 |
Low | 1.66 |
Bid | 1.66 |
Offer | 1.85 |
Previous close | 1.79 |
Average volume | 78.29k |
---|---|
Shares outstanding | 272.36m |
Free float | 267.26m |
P/E (TTM) | -- |
Market cap | 547.44m USD |
EPS (TTM) | -1.14 USD |
Data delayed at least 15 minutes, as of Jun 11 2024 07:03 BST.
More ▼